LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 0.5318 | 0.0875 | 0.3638 | 0.1250 |
MDA-MB-231 | PLX-4720 | 0.37 | uM | LJP5 | 1.0126 | 0.0088 | 1.0171 | 0.0119 |
MDA-MB-231 | QL-X-138 | 0.37 | uM | LJP6 | 0.7835 | 0.0265 | 0.7067 | 0.0365 |
MDA-MB-231 | QL-XII-47 | 0.37 | uM | LJP6 | 0.4616 | 0.0572 | 0.2707 | 0.0786 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 0.4341 | 0.0350 | 0.2332 | 0.0512 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 0.4394 | 0.0494 | 0.2396 | 0.0736 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 0.9375 | 0.0297 | 0.9160 | 0.0392 |
MDA-MB-231 | Ruxolitinib | 0.37 | uM | LJP5 | 0.9472 | 0.0482 | 0.9287 | 0.0651 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 1.0284 | 0.0310 | 1.0387 | 0.0422 |
MDA-MB-231 | Saracatinib | 0.37 | uM | LJP6 | 0.6381 | 0.0305 | 0.5096 | 0.0428 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 0.6042 | 0.0398 | 0.4648 | 0.0500 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 0.8235 | 0.0271 | 0.7603 | 0.0390 |
MDA-MB-231 | Sorafenib | 0.37 | uM | LJP6 | 0.9219 | 0.0511 | 0.8955 | 0.0677 |
MDA-MB-231 | SU11274 | 0.37 | uM | LJP5 | 1.0103 | 0.0159 | 1.0135 | 0.0214 |
MDA-MB-231 | Fedratinib | 0.37 | uM | LJP5 | 0.8948 | 0.0476 | 0.8569 | 0.0658 |
MDA-MB-231 | TGX221 | 0.37 | uM | LJP5 | 0.8473 | 0.0573 | 0.7945 | 0.0751 |
MDA-MB-231 | Torin1 | 0.37 | uM | LJP6 | 0.3991 | 0.0203 | 0.1857 | 0.0353 |
MDA-MB-231 | Torin2 | 0.37 | uM | LJP5 | 0.2902 | 0.0247 | 0.0381 | 0.0420 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 0.3102 | 0.0086 | 0.0658 | 0.0142 |
MDA-MB-231 | Trametinib | 0.37 | uM | LJP5 | 0.3248 | 0.0153 | 0.0851 | 0.0293 |
MDA-MB-231 | TWS119 | 0.37 | uM | LJP5 | 0.9409 | 0.0298 | 0.9192 | 0.0412 |
MDA-MB-231 | Vemurafenib | 0.37 | uM | LJP5 | 0.9719 | 0.0267 | 0.9627 | 0.0359 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 0.7073 | 0.0770 | 0.6036 | 0.1045 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP6 | 0.6256 | 0.0742 | 0.4929 | 0.1006 |
MDA-MB-231 | WYE-125132 | 0.37 | uM | LJP6 | 0.4400 | 0.0532 | 0.2402 | 0.0793 |